Brief: Hydreight Technologies Inc. Announces Strategic Investment In Insu Therapeutics To Advance Needle-Free Peptide Delivery Technology
05/03/2026 13:01
March 5 (Reuters) - Hydreight Technologies Inc NURS.V: HYDREIGHT TECHNOLOGIES INC. ANNOUNCES STRATEGIC INVESTMENT IN INSU THERAPEUTICS TO ADVANCE NEEDLE-FREE PEPTIDE DELIVERY TECHNOLOGY Source text: ID:nCNW9bmQWa Further company coverage: NURS.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hydreight Technologies
See all newsBrief: Hydreight Technologies Inc. Announces Strategic Investment In Insu Therapeutics To Advance Needle-Free Peptide Delivery Technology
Brief: Hydreight Technologies Signs Binding Letter Of Intent To Acquire Dynamic Iv Therapy Support Ai Agent
Brief: Hydreight Announces Closing Of Its Oversubscribed $11.5 Million Convertible Debenture Offering, Including Full Exercise Of Over-Allotment Option
Brief: Hydreight Announces Up To $10 Million Convertible Debenture Offering
Brief: Hydreight Technologies Appoints Roebuck As Director